MAPK3 and neoplasm: The activation of MAPK/ERK1/2 signaling stimulates immature DCs to undergo endothelial-like differentiation within the tumor microenvironment derived from the human esophageal squamous cell carcinoma cells and represents an alternative pathway of tumor angiogenesis (84, 85).